“Adverse Reactions Due to Monoclonal Antibodies in the Treatment of Allergic Diseases. Group Positioning: Comité De Alergia a Medicamentos Del Colegio Mexicano De Inmunología Clínica Y Alergia (CMICA 2024-2025)”. Revista Alergia México 72, no. 1 (March 31, 2025): 52–71. Accessed September 23, 2026. https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1433.